A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
United States Department of Defense
Study ID
NCT06990191
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Partnered Prolonged Exposure (PPE) — BEHAVIORAL
    The PPE condition adapts the PE protocol with strategies from Integrative Behavioral Couples Therapy (an evidence-based couple therapy. PPE involves twice-weekly 60-minute sessions, with some sessions completed by both the Veteran and their partner while others are with the Veteran only.
  • Prolonged Exposure (PE) — BEHAVIORAL
    The PE condition will follow the standardized PE manual and involve weekly 90-minute sessions and a 30-minute check-in attended only by the Veteran and the therapist.

Study Details

PTSD occurs in up to 17% of post-9/11 US Service Members and is associated with long-term functional impairment, family problems, unemployment, and suicidality. Trauma-focused therapies (TFTs), such as Prolonged Exposure (PE), result in significant relief for many. Yet, TFTs are not equally effective for everyone. An important minority (\~40%) will retain their PTSD diagnoses after treatment, and many discontinue treatment prematurely, especially post-9/11 Service Members. TFTs are also more effective in addressing symptoms than psychosocial functioning. More work is needed to improve the consistency and potency of TFTs. Partnering with significant others may provide a powerful method for helping individuals get more out of their PTSD treatment. Observational research shows that relationship factors can help patients initiate, stay in, and experience greater benefit from PTSD treatment. Veterans that were surveyed experienced greater treatment gains when they shared more about their treatment with loved ones and when loved ones accommodated less for PTSD symptoms. Despite the promise of partner-involved interventions, there is no couples approach to PTSD treatment that has demonstrated superior outcomes to individual-only treatment models (i.e., TFTs). To address this gap, the investigators have completed a series of partner-assisted PTSD treatment studies, leading up the current proposal (Partnered PE, PPE). The investigators found that treatment completion rates were better than routine clinical care, and the treatment led to large improvements in participants' functioning, PTSD symptoms, and romantic functioning. For this proposed study, the primary objective is to conduct a randomized controlled trial (Research Level 3; larger-scale clinical trial) to test the superiority of PPE to standard PE among post 9/11 Veterans. The investigator's primary hypothesis is that PPE will lead to greater improvements in psychosocial functioning than standard PE. Secondary and tertiary aims examine posttreatment clinical outcomes (PTSD, depression) and intimate partner outcomes (relationship functioning, distress, caregiver burden, and psychosocial functioning), as well as examine strategies for PPE implementation. In exploratory aims, the investigators will examine the stability of group differences, treatment completion rates, the role military sexual trauma history, and treatment mechanisms.

Key Dates

Start date
May 16, 2025
Status verified
May 2025
Primary completion
Aug 31, 2028
Completion
Aug 31, 2028

Study Design

Enrollment
420 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Prolonged Exposure (PE)
  • Experimental: Partnered Prolonged Exposure (PPE)

Primary Outcome Measure

Inventory of Psychosocial Functioning (IPF) [ Time Frame: Baseline, mid-treatment (between session 5-6), posttreatment (immediately after treatment closes), and 3-months and 6-months after treatment closes. ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
Phoenix VA Healthcare SystemPhoenixArizona85012
Donald Lemon
(612) 467-1957
Brandi Luedtke (PRINCIPAL_INVESTIGATOR)
Courtney Baker (PRINCIPAL_INVESTIGATOR)
San Diego VA Healthcare SystemSan DiegoCalifornia92161
Alex Lin
(858) 552-8585
Alejandra Infante (PRINCIPAL_INVESTIGATOR)
Minneapolis VA Healthcare SystemMinneapolisMinnesota55417
Emily M Hudson, PhD
612-629-7262
Donald Lemon
612-467-1957
Charleston VA Healthcare SystemCharlestonSouth Carolina29401
Sarah Szafranski
843-543-0482
Ursula Myers, PhD (PRINCIPAL_INVESTIGATOR)
Stephanie Kellar (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

Related Studies